Kardium, the developer of a pulsed field ablation and mapping system to treat atrial fibrillation (AFib), said Tuesday it has raised $104 million in a new financing round to help the company prepare for commercial launch.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,